AR and acute myeloid leukemia: To determine the effect of IL-6 signaling on AR expressions, primary AML samples were treated with 10 ng/ml IL-6 for 48 (n = 6) and 72 h (n = 13) and assessed by Western blotting (Fig. 3B, C).